2023-08-012024-07-312024-07-31false12473029LIME INTERNATIONAL HEALTH LIMITED2025-03-19falseiso4217:GBPxbrli:pure124730292023-08-01124730292024-07-31124730292023-08-012024-07-31124730292022-08-01124730292023-07-31124730292022-08-012023-07-3112473029bus:SmallEntities2023-08-012024-07-3112473029bus:AuditExempt-NoAccountantsReport2023-08-012024-07-3112473029bus:AbridgedAccounts2023-08-012024-07-3112473029bus:PrivateLimitedCompanyLtd2023-08-012024-07-3112473029core:WithinOneYear2024-07-3112473029core:AfterOneYear2024-07-3112473029core:WithinOneYear2023-07-3112473029core:AfterOneYear2023-07-3112473029core:ShareCapital2024-07-3112473029core:SharePremium2024-07-3112473029core:RevaluationReserve2024-07-3112473029core:OtherReservesSubtotal2024-07-3112473029core:RetainedEarningsAccumulatedLosses2024-07-3112473029core:ShareCapital2023-07-3112473029core:SharePremium2023-07-3112473029core:RevaluationReserve2023-07-3112473029core:OtherReservesSubtotal2023-07-3112473029core:RetainedEarningsAccumulatedLosses2023-07-3112473029core:LandBuildings2024-07-3112473029core:PlantMachinery2024-07-3112473029core:Vehicles2024-07-3112473029core:FurnitureFittings2024-07-3112473029core:OfficeEquipment2024-07-3112473029core:NetGoodwill2024-07-3112473029core:IntangibleAssetsOtherThanGoodwill2024-07-3112473029core:ListedExchangeTraded2024-07-3112473029core:UnlistedNon-exchangeTraded2024-07-3112473029core:LandBuildings2023-07-3112473029core:PlantMachinery2023-07-3112473029core:Vehicles2023-07-3112473029core:FurnitureFittings2023-07-3112473029core:OfficeEquipment2023-07-3112473029core:NetGoodwill2023-07-3112473029core:IntangibleAssetsOtherThanGoodwill2023-07-3112473029core:ListedExchangeTraded2023-07-3112473029core:UnlistedNon-exchangeTraded2023-07-3112473029core:LandBuildings2023-08-012024-07-3112473029core:PlantMachinery2023-08-012024-07-3112473029core:Vehicles2023-08-012024-07-3112473029core:FurnitureFittings2023-08-012024-07-3112473029core:OfficeEquipment2023-08-012024-07-3112473029core:NetGoodwill2023-08-012024-07-3112473029core:IntangibleAssetsOtherThanGoodwill2023-08-012024-07-3112473029core:ListedExchangeTraded2023-08-012024-07-3112473029core:UnlistedNon-exchangeTraded2023-08-012024-07-3112473029core:MoreThanFiveYears2023-08-012024-07-3112473029core:Non-currentFinancialInstruments2024-07-3112473029core:Non-currentFinancialInstruments2023-07-3112473029dpl:CostSales2023-08-012024-07-3112473029dpl:DistributionCosts2023-08-012024-07-3112473029core:LandBuildings2023-08-012024-07-3112473029core:PlantMachinery2023-08-012024-07-3112473029core:Vehicles2023-08-012024-07-3112473029core:FurnitureFittings2023-08-012024-07-3112473029core:OfficeEquipment2023-08-012024-07-3112473029dpl:AdministrativeExpenses2023-08-012024-07-3112473029core:NetGoodwill2023-08-012024-07-3112473029core:IntangibleAssetsOtherThanGoodwill2023-08-012024-07-3112473029dpl:GroupUndertakings2023-08-012024-07-3112473029dpl:ParticipatingInterests2023-08-012024-07-3112473029dpl:GroupUndertakingscore:ListedExchangeTraded2023-08-012024-07-3112473029core:ListedExchangeTraded2023-08-012024-07-3112473029dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-08-012024-07-3112473029core:UnlistedNon-exchangeTraded2023-08-012024-07-3112473029dpl:CostSales2022-08-012023-07-3112473029dpl:DistributionCosts2022-08-012023-07-3112473029core:LandBuildings2022-08-012023-07-3112473029core:PlantMachinery2022-08-012023-07-3112473029core:Vehicles2022-08-012023-07-3112473029core:FurnitureFittings2022-08-012023-07-3112473029core:OfficeEquipment2022-08-012023-07-3112473029dpl:AdministrativeExpenses2022-08-012023-07-3112473029core:NetGoodwill2022-08-012023-07-3112473029core:IntangibleAssetsOtherThanGoodwill2022-08-012023-07-3112473029dpl:GroupUndertakings2022-08-012023-07-3112473029dpl:ParticipatingInterests2022-08-012023-07-3112473029dpl:GroupUndertakingscore:ListedExchangeTraded2022-08-012023-07-3112473029core:ListedExchangeTraded2022-08-012023-07-3112473029dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-08-012023-07-3112473029core:UnlistedNon-exchangeTraded2022-08-012023-07-3112473029core:NetGoodwill2024-07-3112473029core:IntangibleAssetsOtherThanGoodwill2024-07-3112473029core:LandBuildings2024-07-3112473029core:PlantMachinery2024-07-3112473029core:Vehicles2024-07-3112473029core:FurnitureFittings2024-07-3112473029core:OfficeEquipment2024-07-3112473029core:AfterOneYear2024-07-3112473029core:WithinOneYear2024-07-3112473029core:ListedExchangeTraded2024-07-3112473029core:UnlistedNon-exchangeTraded2024-07-3112473029core:ShareCapital2024-07-3112473029core:SharePremium2024-07-3112473029core:RevaluationReserve2024-07-3112473029core:OtherReservesSubtotal2024-07-3112473029core:RetainedEarningsAccumulatedLosses2024-07-3112473029core:NetGoodwill2023-07-3112473029core:IntangibleAssetsOtherThanGoodwill2023-07-3112473029core:LandBuildings2023-07-3112473029core:PlantMachinery2023-07-3112473029core:Vehicles2023-07-3112473029core:FurnitureFittings2023-07-3112473029core:OfficeEquipment2023-07-3112473029core:AfterOneYear2023-07-3112473029core:WithinOneYear2023-07-3112473029core:ListedExchangeTraded2023-07-3112473029core:UnlistedNon-exchangeTraded2023-07-3112473029core:ShareCapital2023-07-3112473029core:SharePremium2023-07-3112473029core:RevaluationReserve2023-07-3112473029core:OtherReservesSubtotal2023-07-3112473029core:RetainedEarningsAccumulatedLosses2023-07-3112473029core:NetGoodwill2022-08-0112473029core:IntangibleAssetsOtherThanGoodwill2022-08-0112473029core:LandBuildings2022-08-0112473029core:PlantMachinery2022-08-0112473029core:Vehicles2022-08-0112473029core:FurnitureFittings2022-08-0112473029core:OfficeEquipment2022-08-0112473029core:AfterOneYear2022-08-0112473029core:WithinOneYear2022-08-0112473029core:ListedExchangeTraded2022-08-0112473029core:UnlistedNon-exchangeTraded2022-08-0112473029core:ShareCapital2022-08-0112473029core:SharePremium2022-08-0112473029core:RevaluationReserve2022-08-0112473029core:OtherReservesSubtotal2022-08-0112473029core:RetainedEarningsAccumulatedLosses2022-08-0112473029core:AfterOneYear2023-08-012024-07-3112473029core:WithinOneYear2023-08-012024-07-3112473029core:Non-currentFinancialInstrumentscore:CostValuation2023-08-012024-07-3112473029core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-08-012024-07-3112473029core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-08-012024-07-3112473029core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-08-012024-07-3112473029core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-08-012024-07-3112473029core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-08-012024-07-3112473029core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-08-012024-07-3112473029core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-08-012024-07-3112473029core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-08-012024-07-3112473029core:Non-currentFinancialInstrumentscore:CostValuation2024-07-3112473029core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-07-3112473029core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-07-3112473029core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-07-3112473029core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-07-3112473029core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-07-3112473029core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-07-3112473029core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-07-3112473029core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-07-3112473029core:Non-currentFinancialInstrumentscore:CostValuation2023-07-3112473029core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-07-3112473029core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-07-3112473029core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-07-3112473029core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-07-3112473029core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-07-3112473029core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-07-3112473029core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-07-3112473029core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-07-3112473029bus:Director12023-08-012024-07-31

LIME INTERNATIONAL HEALTH LIMITED

Registered Number
12473029
(England and Wales)

Unaudited Financial Statements for the Year ended
31 July 2024

LIME INTERNATIONAL HEALTH LIMITED
Company Information
for the year from 1 August 2023 to 31 July 2024

Director

WILLIAMS, Shaun

Registered Address

Level 30, Leadenhall Building
122 Leadenhall Street
London
EC3V 4AB

Registered Number

12473029 (England and Wales)
LIME INTERNATIONAL HEALTH LIMITED
Balance Sheet as at
31 July 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets34,582-
4,582-
Current assets
Debtors15,22640,382
Cash at bank and on hand335
15,22940,417
Creditors amounts falling due within one year(414,700)(280,960)
Net current assets (liabilities)(399,471)(240,543)
Total assets less current liabilities(394,889)(240,543)
Net assets(394,889)(240,543)
Capital and reserves
Called up share capital1,0001,000
Profit and loss account(395,889)(241,543)
Shareholders' funds(394,889)(240,543)
The financial statements were approved and authorised for issue by the Director on 19 March 2025, and are signed on its behalf by:
WILLIAMS, Shaun
Director
Registered Company No. 12473029
LIME INTERNATIONAL HEALTH LIMITED
Notes to the Financial Statements
for the year ended 31 July 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:
2.Average number of employees

20242023
Average number of employees during the year11
3.Tangible fixed assets

Total

£
Cost or valuation
Additions4,582
At 31 July 244,582
Net book value
At 31 July 244,582
At 31 July 23-
4.Related party transactions
There is a debtor balance of £1020 with Lime Corporate Services Ltd, £1000 of which represents opening share capital of which 100% is owned by that company. (£1000 debtor at end of prior period). There is a creditor balance of £60000 with Lime Global Ltd (Nil balance at the end of the prior period). There is a creditor balance of £35 with Lime International Ltd (Nil at the end of the prior period). There is a creditor balance of £327021 with Lime International Partners Ltd (£10500 debtor balance at the end of the prior period). There is a £35 debtor balance with Lime International Services Ltd (Nil at the end of the prior period). £128996 of the IT Software and Consumables costs were recharges from Lime International Partners Ltd (£222965 prior period).
5.Controlling party
The ultimate controlling party is Lime Global Ltd.